Petra Christine Feyer

Summary

Country: Germany

Publications

  1. ncbi Granisetron in the control of radiotherapy-induced nausea and vomiting: a comparison with other antiemetic therapies
    Petra Feyer
    Clinic of Radiooncology and Nuclear Medicine, Vivantes Clinics Neukoelln, 12351 Berlin, Germany
    Support Care Cancer 13:671-8. 2005
  2. ncbi Radiotherapy-induced nausea and vomiting (RINV): antiemetic guidelines
    Petra Ch Feyer
    Department of Radiotherapy, Nuclear Medicine, Vivantes Medical Center Berlin Neukölln, Rudower Str 48, 12351 Berlin, Germany
    Support Care Cancer 13:122-8. 2005
  3. ncbi DEGRO Practical Guidelines for palliative radiotherapy of breast cancer patients: brain metastases and leptomeningeal carcinomatosis
    Petra Feyer
    Klinikum Neukölln, Berlin, Germany
    Strahlenther Onkol 186:63-9. 2010
  4. ncbi Radiotherapy-induced nausea and vomiting (RINV): MASCC/ESMO guideline for antiemetics in radiotherapy: update 2009
    Petra Christine Feyer
    Department of Radiotherapy, Nuclear Medicine, Vivantes Medical Center Berlin Neukölln, Rudower Str 48, 12351 Berlin, Germany
    Support Care Cancer 19:S5-14. 2011
  5. ncbi Update and new trends in antiemetic therapy: the continuing need for novel therapies
    P Feyer
    Department of Radiooncology, Nuclear Medicine, Vivantes Clinics Berlin Neukölln, Berlin
    Ann Oncol 22:30-8. 2011
  6. ncbi [On the interaction of adjuvant radiotherapy and tamoxifen treatment for breast cancer]
    Ulrike Hoeller
    Klinik fur Strahlentherapie, Radioonkologie und Nuklearmedizin, Vivantes Klinikum Neukölln, Berlin
    Strahlenther Onkol 183:535-44. 2007
  7. ncbi Frequency of side effects in outpatient cancer care and their influence on patient satisfaction--a prospective survey using the PASQOC questionnaire
    Petra Feyer
    Radioonkologie und Radiotherapie, Vivantes Klinikum Berlin Neukoelln, Berlin, Germany
    Support Care Cancer 16:567-75. 2008
  8. ncbi Evidence-based recommendations for the use of antiemetics in radiotherapy
    Ernesto Maranzano
    Radiation Oncology Centre, S Maria Hospital, Terni, Italy
    Radiother Oncol 76:227-33. 2005

Detail Information

Publications8

  1. ncbi Granisetron in the control of radiotherapy-induced nausea and vomiting: a comparison with other antiemetic therapies
    Petra Feyer
    Clinic of Radiooncology and Nuclear Medicine, Vivantes Clinics Neukoelln, 12351 Berlin, Germany
    Support Care Cancer 13:671-8. 2005
    ..In this paper the clinical experience with granisetron in RINV is reviewed, and its efficacy and safety compared with other antiemetic therapies...
  2. ncbi Radiotherapy-induced nausea and vomiting (RINV): antiemetic guidelines
    Petra Ch Feyer
    Department of Radiotherapy, Nuclear Medicine, Vivantes Medical Center Berlin Neukölln, Rudower Str 48, 12351 Berlin, Germany
    Support Care Cancer 13:122-8. 2005
    ..They offer guidance to prescribing physicians for effective antiemetic therapies in RINV...
  3. ncbi DEGRO Practical Guidelines for palliative radiotherapy of breast cancer patients: brain metastases and leptomeningeal carcinomatosis
    Petra Feyer
    Klinikum Neukölln, Berlin, Germany
    Strahlenther Onkol 186:63-9. 2010
    ..To provide recommendations for palliative treatment of brain metastases (BM) and leptomeningeal carcinomatosis (LC) in breast cancer patients with specific emphasis on radiooncologic aspects...
  4. ncbi Radiotherapy-induced nausea and vomiting (RINV): MASCC/ESMO guideline for antiemetics in radiotherapy: update 2009
    Petra Christine Feyer
    Department of Radiotherapy, Nuclear Medicine, Vivantes Medical Center Berlin Neukölln, Rudower Str 48, 12351 Berlin, Germany
    Support Care Cancer 19:S5-14. 2011
    ..This updated guideline offers guidance to the treating physicians for effective antiemetic therapies in RINV...
  5. ncbi Update and new trends in antiemetic therapy: the continuing need for novel therapies
    P Feyer
    Department of Radiooncology, Nuclear Medicine, Vivantes Clinics Berlin Neukölln, Berlin
    Ann Oncol 22:30-8. 2011
    ..This review focuses on the current understanding of CINV, problems associated with its management and the status of promising antiemetic therapies...
  6. ncbi [On the interaction of adjuvant radiotherapy and tamoxifen treatment for breast cancer]
    Ulrike Hoeller
    Klinik fur Strahlentherapie, Radioonkologie und Nuklearmedizin, Vivantes Klinikum Neukölln, Berlin
    Strahlenther Onkol 183:535-44. 2007
    ..Tamoxifen (TAM) is well established in the adjuvant therapy of breast cancer. However, the timing of TAM therapy, concurrent or after radiotherapy, is controversial...
  7. ncbi Frequency of side effects in outpatient cancer care and their influence on patient satisfaction--a prospective survey using the PASQOC questionnaire
    Petra Feyer
    Radioonkologie und Radiotherapie, Vivantes Klinikum Berlin Neukoelln, Berlin, Germany
    Support Care Cancer 16:567-75. 2008
    ..The aims of the study were to examine the frequency of side effects and fatigue in ambulatory cancer patients and to analyse how these symptoms are reflected in patient satisfaction...
  8. ncbi Evidence-based recommendations for the use of antiemetics in radiotherapy
    Ernesto Maranzano
    Radiation Oncology Centre, S Maria Hospital, Terni, Italy
    Radiother Oncol 76:227-33. 2005
    ..To report recommendations given in the Multinational Association of Supportive Care in Cancer (MASCC) International Consensus Conference regarding the use of antiemetics in radiotherapy...